A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 30000 participants.

Also called NCT05893420

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; triple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 30,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05893420
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05893420. Non-randomized; triple masking; primary purpose prevention. Start 2024-12-31 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning
Condition
Sepsis
Condition
Septicemia
Condition
Respiratory Failure
Condition
Hemodynamic Instability
Condition
COVID-19
Condition
Clinical Deterioration
Intervention (Device)
eCARTv5 clinical deterioration monitoring
Intervention (Other)
Standard of care control
Lead sponsor
AgileMD, Inc. (class: industry)
Collaborator
Biomedical Advanced Research and Development Authority (class: US federal agency)
Collaborator
University of Chicago (class: other)
Collaborator
BayCare Health System (class: other)
Collaborator
University of Wisconsin, Madison (class: other)
Collaborator
Yale University (class: other)

Record details

Record id
cardio:ct-nct05893420
Content hash
9d2b967c17df631851bc50798e197972bd7e60c8983ad5ae0a863b777bac080c